NAL Pharmaceuticals Ltd is an emerging drug developer that applies the company's proprietary Bio-FX, Bio-D3 and Bio-CR Drug Delivery System (“DDS”) Technologies to develop unique dosage forms and delivery systems that include Fast Onset (“Bio-FX”), Transdermal Delivery (“Bio-D3”), and Controlled Release (“Bio-CR”) drug products.